UnitedHealth Group Incorporated (NYSE:UNH) is Pinnacle West Asset Management Inc.’s 6th Largest Position

Pinnacle West Asset Management Inc. decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,105 shares of the healthcare conglomerate’s stock after selling 25 shares during the period. UnitedHealth Group accounts for about 2.6% of Pinnacle West Asset Management Inc.’s investment portfolio, making the stock its 6th biggest position. Pinnacle West Asset Management Inc.’s holdings in UnitedHealth Group were worth $3,594,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of UNH. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group during the third quarter worth $37,000. DecisionPoint Financial LLC lifted its holdings in UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares during the period. Highline Wealth Partners LLC purchased a new stake in UnitedHealth Group during the third quarter worth $55,000. Finally, Legacy Investment Solutions LLC purchased a new stake in UnitedHealth Group during the third quarter worth $57,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, Barclays cut their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Up 1.9 %

UNH stock opened at $470.49 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a market cap of $432.99 billion, a price-to-earnings ratio of 30.35, a PEG ratio of 1.37 and a beta of 0.61. The business’s 50-day moving average is $518.22 and its 200 day moving average is $559.08.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the firm posted $5.83 EPS. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.79%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.